Engineered Escherichia coli Nissle 1917 secreting anti-TNF-α nanobody as a single-strain live biotherapeutic for inflammatory bowel disease
-
By
-
Qiumei Zhu
-
Shitao Feng
-
Zhende Yan
-
Zijian Wang
-
Xinran Huang
-
Changning Sun
-
Bingqiang Zhang
-
Xinrui Li
-
Yuchao Gu
-
July 2, 2026
-
Clinical Scorecard: Genetically Modified Escherichia coli Nissle 1917 Producing Anti-TNF-α Nanobody as a Novel Single-Strain Live Biotherapeutic for Treating Inflammatory Bowel Disease
At a Glance
| Category | Detail |
| Condition | Inflammatory Bowel Disease (IBD) |
| Key Mechanisms | Localized TNF-α neutralization via engineered probiotics |
| Target Population | Patients with IBD, including Crohn’s disease and ulcerative colitis |
| Care Setting | Clinical settings for IBD treatment |
Key Highlights
- EcN-MT1 significantly reduced weight loss and improved disease activity index in murine colitis models.
- Engineered EcN demonstrated high secretion levels of anti-TNF-α nanobody MT1.
- Treatment restored gut microbial diversity and corrected dysbiosis.
- EcN-MT1 showed potent suppression of pro-inflammatory cytokines in macrophages.
- The study highlights the potential of live biotherapeutics for safer IBD therapies.
Guideline-Based Recommendations
Diagnosis
- Diagnosis of IBD should consider clinical, endoscopic, and histological criteria.
Management
- Consider engineered probiotics like EcN-MT1 for localized treatment of IBD.
Monitoring & Follow-up
- Monitor disease activity index and mucosal healing in IBD patients.
Risks
- Current treatments carry risks of systemic immunosuppression and opportunistic infections.
Patient & Prescribing Data
Patients with chronic inflammatory bowel disease.
EcN-MT1 offers a novel approach by delivering localized anti-inflammatory effects without systemic exposure.
Clinical Best Practices
- Utilize engineered probiotics for targeted therapy in IBD.
- Assess gut microbiota diversity as part of treatment evaluation.
- Incorporate monitoring of pro-inflammatory cytokines in treatment plans.
Related Resources & Content